Adhera Therapeutics (previously known as Marina Biotech) is a specialty pharmaceutical company. Its patented technology platform, DyrctAxess provides a range of services, including direct prescription delivery from the manufacturer to the patient, reporting features, real-time monitoring and communications between patients and physicians, automatic patient reminders and refills. The company also offers Prestalia, a drug for the treatment of hypertension.